VAM
BSX icon

Vontobel Asset Management’s Boston Scientific BSX Stock Holding History

Vontobel Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$728M Sell
9,982,924
-991,645
-9% -$63.8M 4.03% 7
2023
Q4 		$668M Buy
10,974,569
+1,015,140
+10% +$54.2M 3.97% 9
2023
Q3 		$565M Sell
9,959,429
-9,685
-0.1% -$508K 3.66% 11
2023
Q2 		$577M Sell
9,969,114
-2,509,521
-20% -$131M 3.82% 9
2023
Q1 		$670M Sell
12,478,635
-387,779
-3% -$18.3M 4.84% 6
2022
Q4 		$638M Buy
12,866,414
+248,625
+2% +$10.8M 5.07% 5
2022
Q3 		$535M Sell
12,617,789
-345,012
-3% -$13.8M 4.23% 8
2022
Q2 		$516M Sell
12,962,801
-50,496
-0.4% -$2.06M 3.77% 9
2022
Q1 		$604M Sell
13,013,297
-750,992
-5% -$32.5M 4% 8
2021
Q4 		$613M Buy
13,764,289
+1,988,691
+17% +$83.6M 3.6% 10
2021
Q3 		$532M Sell
11,775,598
-773,964
-6% -$34.2M 2.99% 12
2021
Q2 		$555M Sell
12,549,562
-1,045,307
-8% -$44M 2.85% 10
2021
Q1 		$545M Buy
13,594,869
+1,342,311
+11% +$50.8M 3.31% 9
2020
Q4 		$458M Buy
12,252,558
+2,296,721
+23% +$82.8M 2.7% 10
2020
Q3 		$401M Buy
9,955,837
+1,461,587
+17% +$56.3M 2.41% 12
2020
Q2 		$316M Buy
8,494,250
+166,155
+2% +$5.98M 2.12% 16
2020
Q1 		$293M Buy
8,328,095
+3,027,782
+57% +$118M 2.21% 19
2019
Q4 		$252M Sell
5,300,313
-16,194
-0.3% -$678K 1.6% 23
2019
Q3 		$230M Buy
5,316,507
+442,715
+9% +$18.8M 1.55% 26
2019
Q2 		$216M Buy
4,873,792
+3,462,586
+245% +$133M 1.62% 27
2019
Q1 		$54.2M Sell
1,411,206
-229,266
-14% -$8.76M 0.43% 42
2018
Q4 		$58M Buy
1,640,472
+236,059
+17% +$8.56M 0.5% 43
2018
Q3 		$54.1M Sell
1,404,413
-175,321
-11% -$6.12M 0.41% 47
2018
Q2 		$51.7M Sell
1,579,734
-67,281
-4% -$2.03M 0.38% 47
2018
Q1 		$45M Sell
1,647,015
-4,565
-0.3% -$124K 0.32% 45
2017
Q4 		$40.9M Buy
1,651,580
+266,067
+19% +$7.34M 0.29% 46
2017
Q3 		$40.4M Buy
1,385,513
+728,832
+111% +$20.1M 0.29% 45
2017
Q2 		$18.2M Buy
+656,681
New +$17.4M 0.14% 49

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vontobel Asset Management's BSX Position: Q1 2024 in Review

Vontobel Asset Management reduced its Boston Scientific (BSX) stake by 9% in Q1 2024, selling an estimated $63.8M and leaving 9,982,924 shares worth $728M. The position accounts for 4.03% of the portfolio, ranked #7.

Vontobel Asset Management first reported a position in BSX in Q2 2017 and has held it in 28 quarters since. 1,227 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Vontobel Asset Management held 9,982,924 shares of Boston Scientific worth $728M as of Q1 2024.
  • Vontobel Asset Management sold 991,645 Boston Scientific shares in Q1 2024, an estimated $63.8M.
  • Boston Scientific made up 4.03% of Vontobel Asset Management's portfolio in Q1 2024, its #7 holding.
  • Vontobel Asset Management first reported a position in Boston Scientific in Q2 2017 and has held it in 28 quarters since.
  • 1,227 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Vontobel Asset Management's 13F filing for Q1 2024, filed 15 May 2024.